Immupharma (IMM)

 

ImmuPharma schedules interims

ImmuPharma, the specialist drug discovery and development company, has confirmed that it would announce its results for the six months to the end of June on 27 Sep.

At 9:46am: (LON:IMM) ImmuPharma PLC share price was 0p at 48.5p